U.S. Electrical Stock News

Capital One Financial (NYSE:COF) is pursuing a transformational shift through planned acquisitions of Discover and Brex. The company is repositioning itself toward a technology driven "unbank" model with a bigger presence across consumer and fintech segments. These moves are expected to influence earnings power, return on equity, capital return capacity, and long term growth potential. For investors watching NYSE:COF at a share price of $187.17, the story is increasingly about where the...

Nu Holdings (NYSE:NU) opened Q1 2026 with total revenue of US$1.98 billion and basic EPS of US$0.18, setting a clear marker for its latest quarter at a share price of US$12.19. Over the past year, the company has seen revenue move from US$1.38 billion in Q1 2025 to US$1.98 billion in Q1 2026, while basic EPS moved from US$0.12 to US$0.18 over the same period, framing a steadily larger profit pool for shareholders. Taken together with trailing net income of US$3.18 billion and a reported net...

Core Natural Resources (CNR) has drawn fresh attention after reporting a Q1 2026 swing to profitability, continuing share buybacks and dividends, and outlining new investments in aerospace and defense materials alongside its coal operations. See our latest analysis for Core Natural Resources. Despite the Q1 profit and refreshed commercial leadership, Core Natural Resources’ share price has eased in the short term, with a 30 day share price return of 3.72% down and a 90 day share price return...

Why EMCOR Group Is Back on Investors’ Radar EMCOR Group (EME) is in focus after first quarter 2026 results came in ahead of expectations and management raised full year revenue and EPS guidance, pointing to firm demand in core project markets. See our latest analysis for EMCOR Group. The share price has eased slightly in the past week, with a 1-day share price return of 1.82% lower and a 7-day share price return of 0.93% lower. However, the 30-day and year-to-date share price returns of...

In recent days, Velo3D, Inc. reported first-quarter 2026 results showing revenue of US$13.82 million and a net loss of US$7.00 million, reaffirmed its 2026 revenue guidance of US$60 million to US$70 million, and subsequently filed a US$100 million at-the-market follow-on equity offering alongside a US$63.03 million shelf registration for 3,000,000 common shares. These updates, including a previously announced US$9.80 million five-year contract with the Defense Logistics Agency and improved...

Wondering if Johnson & Johnson at around US$226.71 is still a fair deal, or if the stock has already run too far for comfort. The stock closed at US$226.71, with a 2.4% gain over the last week, a 9.3% gain year to date, and a 54.0% gain over the last year. The past month shows a 3.2% decline that may reflect some cooling or a shift in risk appetite. Recent headlines have focused on Johnson & Johnson's ongoing product portfolio, legal developments, and healthcare sector trends. These factors...

McGrath RentCorp (MGRC) has secured a new five year, US$725 million credit facility that replaces its prior US$650 million line. This financing move directly affects funding capacity and balance sheet flexibility. See our latest analysis for McGrath RentCorp. The new US$725 million facility comes as the share price has eased in the short term, with a 1 month share price return of down 3.15% and a 3 month share price return of down 5.01%. At the same time, the year to date share price return...

Recent performance context Starwood Property Trust (STWD) has been under pressure recently, with the stock down about 6% over the past month and roughly 7% over the past 3 months. This has drawn fresh attention from income focused investors. See our latest analysis for Starwood Property Trust. At a share price of US$17.04, Starwood Property Trust’s recent weakness, including the share price return down around 7% year to date, contrasts with a stronger 3 year total shareholder return of about...

Recent stock performance context for KalVista Pharmaceuticals KalVista Pharmaceuticals (KALV) has drawn fresh attention after a strong share price move, with the stock up about 31% over the past month and roughly 79% over the past 3 months. See our latest analysis for KalVista Pharmaceuticals. That recent surge sits on top of a much stronger long-term picture, with a 1-year total shareholder return of 124.06% and a 3-year total shareholder return of 153.85%, signalling firm upward momentum...

Seritage Growth Properties Q1 2026 Earnings Snapshot Seritage Growth Properties (SRG) has opened Q1 2026 reporting season with recent revenue of US$4.6 million in Q4 2025 and basic EPS of US$0.11 loss per share, setting the tone for how investors will be weighing the latest numbers against past results. The company has seen quarterly revenue move from US$3.4 million in Q3 2024 to US$5.4 million in Q3 2025 and US$4.6 million in Q4 2025. Quarterly basic EPS has ranged from a loss of US$0.41 per...

Dillard’s, Inc. recently reported first-quarter 2026 results, with sales rising to US$1,568.4 million, revenue reaching US$1,588.6 million, and net income increasing to US$250.6 million, supported by a 3% lift in same-store sales and higher retail gross margin. The company’s profitability was further enhanced by a very large pre-tax gain of US$104.1 million from a favorable payment card interchange fee litigation settlement, adding an unusual one-off boost to earnings. We’ll now examine how...

Investors may be wondering whether Quaker Chemical at around US$137.99 is still offering value, or if most of the easy gains are already behind it. The stock is down about 6.5% over the last week and 1.3% over the last month, roughly flat year to date with a 0.7% decline, yet still up 31.1% over the past year after longer term declines of 31.4% over three years and 37.0% over five years. Recent coverage has focused on Quaker Chemical's position in the specialty chemicals sector and how...

Shopify (SHOP) is back in focus after a busy few weeks, with strong Q1 2026 results, cautious guidance, fresh AI debates, legal developments, and a new EZ Texting integration all influencing how investors view the stock. See our latest analysis for Shopify. The recent mix of strong Q1 results, softer near term guidance, AI related cost concerns, and fresh legal and governance headlines has coincided with pressure on the stock, with the share price down 36.21% year to date. However, the three...

eBay stock performance snapshot eBay (EBAY) has drawn fresh attention after recent trading, with the stock last closing at $116.13 and showing positive total returns over the past year and past 3 months. Investors looking at this marketplace platform can also see annual revenue of $11.6b and net income of $2.0b, supported by activity across the United States, the United Kingdom, China and other international markets. See our latest analysis for eBay. The recent 7 day share price return of...

NeoVolta (NEOV) has just posted another loss making quarter, with Q2 2026 revenue at US$4.6 million and a basic EPS loss of US$0.16, alongside net income excluding extra items of a US$5.5 million loss. The company has seen revenue move from US$0.6 million in Q1 2025 to US$6.7 million in Q1 2026, while quarterly EPS has ranged from a loss of US$0.03 to US$0.16 over that stretch. This has left investors focused on how quickly margins can tighten toward breakeven. See our full analysis for...

Q1 2026 headline results set the tone National Presto Industries (NPK) opened 2026 with Q1 revenue of US$118.6 million and basic EPS of US$0.93, putting fresh numbers on the table for investors weighing the recent move in the stock around US$137.98. The company has seen quarterly revenue range from US$103.6 million in Q1 2025 to US$163.9 million in Q4 2025, while basic EPS moved between US$0.72 and US$2.10 over the same period. This gives you a clear sense of how the top and bottom lines have...

Disc Medicine, Inc. reported a first-quarter 2026 net loss of US$63.5 million, with basic loss per share from continuing operations of US$1.65, while also preparing to present new data from multiple hematology programs at the European Hematology Association Congress. The upcoming RALLY-MF phase 2 and bitopertin data presentations at a major hematology meeting highlight how much of Disc Medicine’s story now hinges on clinical progress rather than current earnings. Next, we’ll examine how the...

Horizon Kinetics Holding (OTCPK:HKHC) Q1 2026 results in focus Horizon Kinetics Holding (OTCPK:HKHC) has followed up a volatile 2025 with Q1 2026 results that sit against a trailing 12 month backdrop of US$72.8 million in revenue and Basic EPS of US$0.34, after a year that also included a one off loss of US$33.7 million. Over recent periods, the company has seen quarterly revenue move from US$18.2 million in Q4 2024 to US$19.8 million in Q1 2025, then to US$17.9 million in Q3 2025 and US$17.0...

Workday (WDAY) has come back into focus after strong quarterly earnings, upbeat guidance, and fresh AI product news, including the Sana Self-Service Agent integration into Microsoft 365 Copilot for HR and finance workflows. See our latest analysis for Workday. The 1 day share price gain of 5.3% to about US$125 follows a difficult stretch, with the year to date share price return down 39.3% and the 1 year total shareholder return down 54.2%, so recent AI partnerships and earnings have improved...

The recent drop in Regions Financial (RF) stock was sparked by the Federal Reserve signaling no interest rate cuts in 2026. This stance pressured regional banks as investors reconsidered lending and margin expectations. See our latest analysis for Regions Financial. Beyond the immediate reaction to the Federal Reserve comments, Regions Financial’s share price has been under pressure in recent weeks. The 30 day share price return is down 5.23% and the 90 day share price return is down 10.36%...

Cabot stock at a glance Cabot (CBT) has drawn fresh attention after recent trading left the stock at US$81. For investors, that price sits alongside a reported US$3,575.0m in revenue and US$281.0m in net income. See our latest analysis for Cabot. Recent trading has been choppy, with the share price down over 1 day and over the past week. However, a 30-day share price return of 8.83% and a year-to-date share price return of 20.81% sit alongside a 1-year total shareholder return of 8.39%,...

nVent Electric (NVT) is back in focus after a series of company-specific developments, including record first quarter results, a new US$500 million share repurchase authorization, and confirmation of its regular cash dividend. See our latest analysis for nVent Electric. The stock has pulled back 2.85% on a 1-day share price basis to US$169.01 and is slightly lower over 7 days. However, the 30-day share price return of 25.48% and 1-year total shareholder return of 152.16% point to strong...

In early May 2026, TKO Group Holdings and the Arizona Sports & Events Alliance announced a three-year, seven-event agreement to host premier UFC, WWE, PBR and Zuffa Boxing events in Arizona, alongside TKO reporting first-quarter 2026 revenue of US$1,596.88 million and net income of US$89.35 million with reaffirmed full-year revenue guidance of US$5.68 billion to US$5.78 billion. Together, the Arizona live events deal and the latest quarterly results highlight how TKO is pairing content...

MoonLake Immunotherapeutics (MLTX) has cleared a key regulatory step by completing a final pre-BLA meeting with the FDA for sonelokimab in hidradenitis suppurativa, achieving alignment on efficacy, safety data inclusion, and submission timing. See our latest analysis for MoonLake Immunotherapeutics. Despite the recent pullback, with a 1-day share price return of 4.57% and a 30-day share price return of 4.31% both declining, MoonLake’s share price is still up 46.86% year to date, while the...